Stock Analysis
CleanSpace Holdings (ASX:CSX) Full Year 2024 Results
Key Financial Results
- Revenue: AU$15.7m (up 30% from FY 2023).
- Net loss: AU$3.10m (loss narrowed by 62% from FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
CleanSpace Holdings shares are up 44% from a week ago.
Risk Analysis
Before you take the next step you should know about the 3 warning signs for CleanSpace Holdings (2 are a bit unpleasant!) that we have uncovered.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ASX:CSX
CleanSpace Holdings
Engages in the design, manufacture, and sale of respiratory protection products and services for healthcare and industrial markets worldwide.
